共 3 条
- [1] Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study[J]. LANCET, 2020, 395 (10231) : 1208 - 1216Hofman, Michael S.Lawrentschuk, NathanFrancis, Roslyn J.Tang, ColinVela, IanThomas, PaulRutherford, NatalieMartin, Jarad M.Frydenberg, MarkShakher, RamdaveWong, Lih-MingTaubman, KimLee, Sze TingHsiao, EdwardRoach, PaulNottage, MichelleKirkwood, IanHayne, DickonLink, EmmaMarusic, PetraMatera, AnettaHerschtal, AlanIravani, AmirHicks, Rodney J.Williams, ScottMurphy, Declan G.
- [2] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial[J]. LANCET, 2018, 392 (10162) : 2353 - 2366Parker, Christopher C.James, Nicholas D.Brawley, Christopher D.Clarke, Noel W.Hoyle, Alex P.Ali, AdnanRitchie, Alastair W. S.Attard, GerhardtChowdhury, SimonCross, WilliamDearnaley, David P.Gillessen, SilkeGilson, ClareJones, Robert J.Langley, Ruth E.Malik, Zafar I.Mason, Malcolm D.Matheson, DavidMillman, RobinRussell, J. MartinThalmann, George N.Amos, Claire L.Alonzi, RobertoBahl, AmitBirtle, AlisonDin, OmarDouis, HassanEswar, ChinnamaniGale, JoannaGannon, Melissa R.Jonnada, SaiKhaksar, SaraLester, Jason F.O'Sullivan, Joe M.Parikh, Omi A.Pedley, Ian D.Pudney, Delia M.Sheehan, Denise J.Srihari, Narayanan NairTran, Anna T. H.Parmar, Mahesh K. B.Sydes, Matthew R.
- [3] When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities[J]. EUROPEAN UROLOGY, 2021, 79 (05) : 565 - 567Sundahl, NoraGillessen, SilkeSweeney, ChristopherOst, Piet